Ferretti Elisabetta, De Smaele Enrico, Di Marcotullio Lucia, Screpanti Isabella, Gulino Alberto
Department of Experimental Medicine and Pathology, La Sapienza University, Viale Regina Elena 324, 00161 Rome, Italy.
Trends Mol Med. 2005 Dec;11(12):537-45. doi: 10.1016/j.molmed.2005.10.005. Epub 2005 Nov 14.
Medulloblastomas often activate Hedgehog signaling inappropriately. The finding that mutations in components of this pathway are present only in few tumors suggests that additional genetic or epigenetic lesions can also lead to Hedgehog dysregulation. Chromosome 17p deletion, the most frequently detected genetic lesion in medulloblastoma, has recently been identified as a cause of unrestrained Hedgehog signaling. Such a deletion leads to the loss of REN(KCTD11), a novel Hedgehog antagonist, thus removing a checkpoint of Hedgehog-dependent events during cerebellum development and tumorigenesis. The disruption of additional Hedgehog modulators that map to 17p suggests a rationale for a multitargeted therapeutic strategy aimed at interrupting the cooperative activation of the Hedgehog pathway.
髓母细胞瘤常常异常激活Hedgehog信号通路。该信号通路相关组分的突变仅在少数肿瘤中出现,这一发现提示,其他遗传或表观遗传损伤也可导致Hedgehog信号失调。17号染色体短臂缺失是髓母细胞瘤中最常见的遗传损伤,最近已被确定为Hedgehog信号不受抑制的一个原因。这种缺失导致新型Hedgehog拮抗剂REN(KCTD11)缺失,从而消除了小脑发育和肿瘤发生过程中Hedgehog依赖性事件的一个检查点。定位于17号染色体短臂的其他Hedgehog调节因子的破坏,为旨在中断Hedgehog信号通路协同激活的多靶点治疗策略提供了理论依据。